Certifications

This Health IT Module is compliant with the ONC Certification Criteria for Health IT and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

Vendor Name: ChartLogic, a Division of Medsphere Systems Corporation
Product Version: 9
Date Certified: 12/22/2022
ONC-ABC Certification ID: 15.05.05.1223.CHRT.02.01.1.221222
Modules Tested: 170.315(a)(2-3); 170.315(a)(5); 170.315(a)(9); 170.315(a)(12,14); 170.315(b)(1‐2, 10); 170.315(d)(1‐10, 12-13); 170.315(f)(1‐2, 5); 170.315(g)(3-7); 170.315(h)(1)
Clinical Quality Measures Tested: None (handled through our partners)
Additional Software Used: Change Healthcare Clinical Network V1.3, Surescripts 2017 Edition

EHI Export Documentation:

ChartLogic enables EHI export for both individual and patient populations in the format of Consolidated-Clinical Document Architecture (C-CDA), additionally, documents and images that have been scanned into the system can be exported as PDFs.

Currently the C-CDA complies with the United States Core Data for Interoperability (USCDI), Version 1. The specifications for the C-CDA can be located on the HL7 website:

 HL7^® Implementation Guide for CDA Release 2 Consolidation CDA Templates for Clinical Notes (US Realm), Draft Standard for Trial Use Release 2.1 C-CDA 2.1 with Errata, August 2015, June 2019 (with Errata)

HL7^® CDA R2 IG: C-CDA Templates for Clinical Notes R2.1 Companion Guide, Release 2, October 2019, IBR approved for § 170.205(a)(5).

Costs

The certified product-version may require ongoing monthly costs to support computerized provider order entry provided through Change Healthcare Clinical Exchange and ePrescribe services provided through DrFirst Rcopia. ePrescribe services check for drug-drug and drug-allergy interactions. The ongoing monthly costs are flat rate per provider.

The certified product-version may require one-time costs to establish interfaces for reporting to health information exchanges, immunization registries, and other public health agencies. The one-time cost is charged at the practice level per interface.

The certified product-version uses Surescripts Network for Clinical Interoperability for direct messaging.

SLI CERTIFIED® is a registered trademark of Gaming Laboratories International, LLC dba SLI Compliance.

This Health IT Module is compliant with the ONC Certification Criteria for Health IT and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

Drummond Group is accredited by ANSI and approved by ONC for the ONC Health IT Certification Program to certify Health IT Module(s) and Certification of other types of Health IT for which the Secretary has adopted certification criteria under Subpart C of 45 CFR.

Vendor Name: ChartLogic, a Division of Medsphere Systems Corporation
Product Version: ChartLogic Patient Portal 9
Date Certified: 08/14/2017
ONC-ACB Certification ID: 15.04.04.1223.Char.09.00.1.170814
Modules Tested: 170.315 (b)(10); (d)(1-3, 5, 7, 9, 12-13); (e)(1,3); (g)(4-6)
Clinical Quality Measures Tested: None
Additional Software Used: Surescripts Clinical Direct Messaging

EHI Export Documentation:

ChartLogic Patient Portal enables EHI export for both individual and patient populations in the format of Consolidated-Clinical Document Architecture (C-CDA).

Currently the C-CDA complies with the United States Core Data for Interoperability (USCDI), Version 1. The specifications for the C-CDA can be located on the HL7 website:

 HL7^® Implementation Guide for CDA Release 2 Consolidation CDA Templates for Clinical Notes (US Realm), Draft Standard for Trial Use Release 2.1 C-CDA 2.1 with Errata, August 2015, June 2019 (with Errata)

HL7^® CDA R2 IG: C-CDA Templates for Clinical Notes R2.1 Companion Guide, Release 2, October 2019, IBR approved for § 170.205(a)(5).

Costs